126 related articles for article (PubMed ID: 8587164)
21. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Monteil H; Jehl F
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibilities of feline and canine Escherichia coli and Pseudomonas spp. isolates to ticarcillin and ticarcillin-clavulanic acid.
Bennett AB; Martin PA; Gottlieb SA; Govendir M
Aust Vet J; 2013 May; 91(5):171-8. PubMed ID: 23614511
[TBL] [Abstract][Full Text] [Related]
23. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
Boon RJ; Beale AS; Sutherland R
Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
[TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
Rotstein C; Amsterdam D; Beam T; Gorzynski E
Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
[TBL] [Abstract][Full Text] [Related]
25. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
26. Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa.
Tausk F; Stratton CW
Antimicrob Agents Chemother; 1986 Oct; 30(4):584-9. PubMed ID: 3098162
[TBL] [Abstract][Full Text] [Related]
27. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
Paisley JW; Washington JA
Antimicrob Agents Chemother; 1978 Aug; 14(2):224-7. PubMed ID: 308792
[TBL] [Abstract][Full Text] [Related]
28. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
[TBL] [Abstract][Full Text] [Related]
29. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
[TBL] [Abstract][Full Text] [Related]
30. Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.
Manian FA; Alford RH
Antimicrob Agents Chemother; 1986 Jul; 30(1):35-8. PubMed ID: 3092732
[TBL] [Abstract][Full Text] [Related]
31. [Spread in hospital units of a Pseudomonas aeruginosa phenotype producing a beta-lactamase highly inducible by clavulanic acid in vitro].
Buisson Y; Nizou JY; Talarmin A; Meyran M
Pathol Biol (Paris); 1992 May; 40(5):566-72. PubMed ID: 1495845
[TBL] [Abstract][Full Text] [Related]
32. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.
Joly B; Chanal M; Sirot D; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1986 May; 17 Suppl C():27-33. PubMed ID: 3522530
[TBL] [Abstract][Full Text] [Related]
33. Timentin resistance.
Masterton RG; Garner PJ; Harrison NA; Rainford DJ
Lancet; 1987 Oct; 2(8565):975-6. PubMed ID: 2889900
[No Abstract] [Full Text] [Related]
34. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.
Sirot D; Chanal C; Henquell C; Labia R; Sirot J; Cluzel R
J Antimicrob Chemother; 1994 Jun; 33(6):1117-26. PubMed ID: 7928805
[TBL] [Abstract][Full Text] [Related]
35. [Activities of antibiotics against methicillin-resistant Staphylococcus aureus with particular reference to synergetic effect between ticarcillin and fosfomycin on penicillinase non-producing methicillin-resistant S. aureus].
Morikawa Y; Yoshioka Y; Toshima M
Jpn J Antibiot; 1993 Jun; 46(6):421-7. PubMed ID: 8360977
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
37. Development of beta-lactamase inhibitors.
Sutherland R
J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
[TBL] [Abstract][Full Text] [Related]
38. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
Gill CJ; Ponticas S; Shungu DL; Guerriero S
Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
[TBL] [Abstract][Full Text] [Related]
39. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.
Wise R; Andrews JM; Bedford KA
Antimicrob Agents Chemother; 1978 Mar; 13(3):389-93. PubMed ID: 122520
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
Fuchs PC; Barry AL; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1984 Mar; 25(3):392-4. PubMed ID: 6721472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
